Gifu, Japan

Yukio Kitade


 

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2009-2019

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of Yukio Kitade in Oligonucleotide Derivatives

Introduction

Yukio Kitade is a prominent inventor based in Gifu, Japan, known for his significant contributions to the field of oligonucleotide derivatives. With a total of six patents to his name, Kitade has made remarkable advancements in drug delivery systems and RNA interference agents.

Latest Patents

Among his latest patents, Kitade has developed an oligonucleotide derivative and an oligonucleotide construct that utilize a unique method for production. This oligonucleotide derivative is characterized by its ability to be introduced into cells through the binding of its amino sugar chain moiety to ligands on cell surfaces, thereby facilitating selective drug delivery. The synthesis of this derivative is straightforward, allowing for cell introduction without the need for lipofection reagents. Additionally, he has created an RNA interference agent designed to minimize off-target effects, featuring a single-stranded oligonucleotide passenger strand with low-affinity units at the 3'-end.

Career Highlights

Kitade has had a distinguished career, working with esteemed institutions such as Gifu University and the Japan Science and Technology Agency. His work has been pivotal in advancing the understanding and application of oligonucleotide technology in therapeutic contexts.

Collaborations

Throughout his career, Kitade has collaborated with notable colleagues, including Yoshihito Ueno and Aya Shibata, contributing to a rich exchange of ideas and innovations in his field.

Conclusion

Yukio Kitade's innovative work in oligonucleotide derivatives and RNA interference agents showcases his commitment to advancing medical science. His contributions have the potential to significantly impact drug delivery systems and therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…